P9047 - Infusion, albumin (human), 25%, 50 ml |
50 ML |
52.45 |
- |
- |
- |
- |
95% |
52.45 |
|
|
Q0138 - Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
1 MG |
0.533 |
- |
- |
- |
- |
- |
- |
|
|
Q0139 - Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) |
1 MG |
0.533 |
- |
- |
- |
- |
- |
- |
|
|
Q0162 - Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1 MG |
0.014 |
- |
- |
- |
- |
- |
- |
|
|
Q0167 - Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2.5 MG |
0.839 |
- |
- |
- |
- |
- |
- |
|
|
Q0222 - Injection, bebtelovimab, 175 mg |
175 MG |
2394 |
- |
- |
- |
- |
- |
- |
|
|
Q2043 - Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion |
Per infusion (minimum 50 million cells) |
53505.534 |
- |
- |
- |
- |
- |
- |
|
|
Q2050 - Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg |
10 MG |
111.985 |
- |
- |
- |
- |
- |
- |
|
|
Q3027 - Injection, interferon beta-1a, 1 mcg for intramuscular use |
1 MCG |
54.833 |
- |
- |
- |
- |
- |
- |
|
|
Q4074 - Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms |
UP TO 20 MCG |
139.224 |
- |
- |
- |
- |
- |
- |
|
|
Q4081 - Injection, epoetin alfa, 100 units (for esrd on dialysis) |
100 UNITS |
0.837 |
- |
- |
- |
- |
- |
- |
|
|
Q4101 - Apligraf, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
30.514 |
- |
- |
- |
- |
- |
- |
|
|
Q4102 - Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
12.03 |
- |
- |
- |
- |
- |
- |
|
|
Q4106 - Dermagraft, per square centimeter |
1 SQ CM |
25.538 |
- |
- |
- |
- |
- |
- |
|
|
Q4110 - Primatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
42.41 |
- |
- |
- |
- |
- |
- |
|
|
Q4111 - Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
7.207 |
- |
- |
- |
- |
- |
- |
|
|
Q4121 - Theraskin, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
44.541 |
- |
- |
- |
- |
- |
- |
|
|
Q4133 - Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
135.42 |
- |
- |
- |
- |
- |
- |
|
|
Q4137 - Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
97.365 |
- |
- |
- |
- |
- |
- |
|
|
Q4151 - Amnioband or guardian, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
133.666 |
- |
- |
- |
- |
- |
- |
|
|
Q4159 - Affinity, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
470.927 |
- |
- |
- |
- |
- |
- |
|
|
Q4160 - Nushield, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
93.83 |
- |
- |
- |
- |
- |
- |
|
|
Q4163 - Woundex, bioskin, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
97.365 |
- |
- |
- |
- |
- |
- |
|
|
Q4186 - Epifix, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
156.17 |
- |
- |
- |
- |
- |
- |
|
|
Q4187 - Epicord, per square centimeter (add-on, list separately in addition to primary procedure) |
1 SQ CM |
235.879 |
- |
- |
- |
- |
- |
- |
|
|